Literature DB >> 973947

Comparative value of rating scales.

M Hamilton.   

Abstract

Mesh：

Year:  1976        PMID： 973947      PMCID： PMC2958734          DOI： 10.1111/j.1365-2125.1976.tb03714.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  ADJECTIVE CHECKLISTS FOR MEASUREMENT OF DEPRESSION.

Authors:  B LUBIN
Journal:  Arch Gen Psychiatry       Date:  1965-01

2.  VALIDATION OF AN INVENTORY FOR MEASURING DEPRESSION.

Authors:  M METCALFE; E GOLDMAN
Journal:  Br J Psychiatry       Date:  1965-03       Impact factor: 9.319

3.  Depression scales: self- or physician-rating? A validation of certain clinically observable phenomena.

Authors:  G L Brown; W W Zung
Journal:  Compr Psychiatry       Date:  1972 Jul-Aug       Impact factor: 3.735

4.  Measurement of mood.

Authors:  A K Zealley; R C Aitken
Journal:  Proc R Soc Med       Date:  1969-10

5.  M.P.I. scores and symptoms of depression.

Authors:  R F Garside; D W Kay; J R Roy; P Beamish
Journal:  Br J Psychiatry       Date:  1970-04       Impact factor: 9.319

6.  [Evaluation scale in depressive conditions].

Authors:  J Bojanovský; K Chloupková
Journal:  Psychiatr Neurol (Basel)       Date:  1966

7.  A comparison of two rating scales for depression.

Authors:  J J Schwab; M R Bialow; C E Holzer
Journal:  J Clin Psychol       Date:  1967-01

8.  Assessment of the severity of primary depressive illness. Wakefield self-assessment depression inventory.

Authors:  R P Snaith; S N Ahmed; S Mehta; M Hamilton
Journal:  Psychol Med       Date:  1971-02       Impact factor: 7.723

9.  The Depression Status Inventory: an adjunct to the Self-Rating Depression Scale.

Authors:  W W Zung
Journal:  J Clin Psychol       Date:  1972-10
  9 in total
  7 in total

1.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

2.  Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

3.  Freezing of gait in Parkinson's disease: gray and white matter abnormalities.

Authors:  Sara Pietracupa; Antonio Suppa; Neeraj Upadhyay; Costanza Giannì; Giovanni Grillea; Giorgio Leodori; Nicola Modugno; Francesca Di Biasio; Alessandro Zampogna; Claudio Colonnese; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2017-11-11       Impact factor: 4.849

Review 4.  The risk-benefit assessment of antidepressant drugs.

Authors:  J A Henry; A J Martin
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

5.  Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.

Authors:  Katrina Gwinn; Karen K David; Christine Swanson-Fischer; Roger Albin; Coryse St Hillaire-Clarke; Beth-Anne Sieber; Codrin Lungu; F DuBois Bowman; Roy N Alcalay; Debra Babcock; Ted M Dawson; Richard B Dewey; Tatiana Foroud; Dwight German; Xuemei Huang; Vlad Petyuk; Judith A Potashkin; Rachel Saunders-Pullman; Margaret Sutherland; David R Walt; Andrew B West; Jing Zhang; Alice Chen-Plotkin; Clemens R Scherzer; David E Vaillancourt; Liana S Rosenthal
Journal:  Biomark Med       Date:  2017-06-23       Impact factor: 2.851

6.  Hamilton depression rating scale and montgomery-asberg depression rating scale in depressed and bipolar I patients: psychometric properties in a Brazilian sample.

Authors:  Adriana Munhoz Carneiro; Fernando Fernandes; Ricardo Alberto Moreno
Journal:  Health Qual Life Outcomes       Date:  2015-04-02       Impact factor: 3.186

7.  The ethics of prescription of placebos to patients with major depressive disorder.

Authors:  Shun-Jie Chua; Mark Pitts
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.